Literature DB >> 30137275

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.

Christian Maaser1, Andreas Sturm2, Stephan R Vavricka3, Torsten Kucharzik4, Gionata Fiorino5, Vito Annese6, Emma Calabrese7, Daniel C Baumgart8, Dominik Bettenworth9, Paula Borralho Nunes10, Johan Burisch11, Fabiana Castiglione12, Rami Eliakim13, Pierre Ellul14, Yago González-Lama15, Hannah Gordon16, Steve Halligan17, Konstantinos Katsanos18, Uri Kopylov13, Paulo G Kotze19, Eduards Krustinš20, Andrea Laghi21, Jimmy K Limdi22, Florian Rieder23, Jordi Rimola24, Stuart A Taylor17, Damian Tolan25, Patrick van Rheenen26, Bram Verstockt27, Jaap Stoker28.   

Abstract

Mesh:

Year:  2019        PMID: 30137275     DOI: 10.1093/ecco-jcc/jjy113

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  216 in total

1.  Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.

Authors:  Steven J Edwards; Samantha Barton; Mariana Bacelar; Charlotta Karner; Peter Cain; Victoria Wakefield; Gemma Marceniuk
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

2.  Are we ready to use activity scores for intestinal ultrasound in ulcerative colitis?

Authors:  Torsten Kucharzik; Christian Maaser; Kerri Novak
Journal:  United European Gastroenterol J       Date:  2021-05-12       Impact factor: 4.623

3.  Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.

Authors:  Bram Verstockt; Charlotte Claeys; Gert De Hertogh; Gert Van Assche; Albert Wolthuis; André D'Hoore; Séverine Vermeire; Marc Ferrante
Journal:  United European Gastroenterol J       Date:  2019-08-20       Impact factor: 4.623

4.  The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels a simple endoscopic index and fecal calprotectin.

Authors:  Joana Roseira; Ana Rita Ventosa; Helena Tavares de Sousa; Jorge Brito
Journal:  United European Gastroenterol J       Date:  2020-07-14       Impact factor: 4.623

5.  A novel PillCam Crohn's capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn's disease.

Authors:  Rami Eliakim; Doron Yablecovitch; Adi Lahat; Bella Ungar; Eyal Shachar; Dan Carter; Limor Selinger; Sandra Neuman; Shomron Ben-Horin; Uri Kopylov
Journal:  United European Gastroenterol J       Date:  2020-03-12       Impact factor: 4.623

Review 6.  IBD in pregnancy: recent advances, practical management.

Authors:  Christian P Selinger; Catherine Nelson-Piercy; Aileen Fraser; Veronica Hall; Jimmy Limdi; Lyn Smith; Marie Smith; Reem Nasur; Melanie Gunn; Andrew King; Aarthi Mohan; Khasia Mulgabal; Alexandra Kent; Klaartje Bel Kok; Tracey Glanville
Journal:  Frontline Gastroenterol       Date:  2020-05-19

Review 7.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

Review 8.  Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.

Authors:  Torsten Kucharzik; Sibylle Koletzko; Klaus Kannengiesser; Axel Dignass
Journal:  Dtsch Arztebl Int       Date:  2020-08-17       Impact factor: 5.594

9.  Pilot case-control study to explore the value of intestinal ultrasound in the differentiation of two common diseases involving the ileocecal region: intestinal Behçet's disease and Crohn's disease.

Authors:  Li Ma; Miaoqian Wang; Wenbo Li; Wei Liu; Hong Yang; Yuxin Jiang; Qingli Zhu
Journal:  Quant Imaging Med Surg       Date:  2021-07

10.  Developing a Neural Network Model for a Non-invasive Prediction of Histologic Activity in Inflammatory Bowel Diseases.

Authors:  Iolanda Valentina Popa; Mircea Diculescu; Catalina Mihai; Cristina Cijevschi Prelipcean; Alexandru Burlacu
Journal:  Turk J Gastroenterol       Date:  2021-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.